Efficacy of Fluvastatin and Fenofibrate in Comparison to Simvastatin and Ezetimibe in Patients With Metabolic Syndrome

NCT00385658 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

75

Enrollment

INDUSTRY

Sponsor class

Conditions

Dyslipidemia

Interventions

DRUG: Fluvastatin extended release, fenofibrate
DRUG: Fixed combination simvastatin/ezetimibe

Sponsor

Novartis